Palladyne AI Q2 Revenue Surges 470% to $5.8M; Backlog Hits $24.6M, Guidance Reiterated
PDYN sits 47% above its 52-week low of $4.14.
Summary
Palladyne AI reported Q2 2026 revenue of $5.8 million, up 470% YoY, with backlog reaching $24.6 million. The company reiterated its full-year revenue guidance of $24-$27 million and expects cash burn to decline in the second half.
Key Events · Earnings and Guidance · PDYN
-
Revenue Surges 470% YoY
Q2 2026 revenue reached $5.8 million, a 470% increase from $1.0 million in Q2 2025, and up 63% sequentially from Q1 2026.
-
Backlog Grows to $24.6M
Backlog as of June 30, 2026 was $24.6 million, up 43% during the quarter, reflecting approximately $13.0 million in new contract awards.
-
Full-Year Guidance Reiterated
Management reiterated 2026 revenue guidance of $24.0-$27.0 million (357%-415% growth) and operating cash burn of ($32.0)-($36.0) million, with cash burn expected to trend lower in H2.
-
Operating Loss Widens on Investments
GAAP operating loss was ($13.4) million vs. ($8.1) million a year ago, driven by higher stock-based compensation ($2.3M) and strategic hiring in the Aerospace and Defense division.
Analysis · PDYN · Technology
Palladyne AI delivered a breakout quarter, with revenue jumping 470% year-over-year to $5.8 million, driven by both acquisitions and organic growth. The $24.6 million backlog, up 43% sequentially, provides strong visibility into the second half, supporting reiterated full-year guidance of $24-$27 million. While operating losses widened to $13.4 million due to strategic hiring and stock-based compensation, the company ended the quarter with $43.7 million in cash and marketable securities, roughly flat to the prior quarter. The exclusive IAI partnership for loitering munitions and multiple new DoD contracts underscore the company's growing defense footprint. The market will focus on the pace of backlog conversion and whether cash burn trends lower as guided.
At the time of this filing, PDYN was trading at $6.10 on NASDAQ in the Technology sector, with a market capitalization of approximately $282M. The 52-week trading range was $4.14 to $10.73. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.